TP53 and cancer: Like the pan-cancer analysis, AM-1882 sensitivity was significantly enriched in TP53-mutant (39%, 16 of 41) relative to TP53-WT (6%, one of 17) cell lines (P value = 8.0 × 10−4; Extended Data Fig. 6b).